• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在纽约市一家医院中,按工作职能和工作地点划分的医护人员中 SARS-CoV-2 血清流行率。

SARS-CoV-2 Seroprevalence Among Healthcare Workers by Job Function and Work Location in a New York Inner-City Hospital.

机构信息

Division of Pediatric Infectious Disease, Department of Pediatrics, BronxCare Health System, Bronx, NY.

Department of Family Medicine, Bronx-Care Health System Bronx, NY.

出版信息

J Hosp Med. 2021 May;16(5):282-289. doi: 10.12788/jhm.3627.

DOI:10.12788/jhm.3627
PMID:33929948
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8086991/
Abstract

OBJECTIVE

To describe the seroprevalence and risk for SARS-CoV-2 among healthcare workers (HCWs) by job function and work location following the pandemic's first wave in New York City (NYC).

METHODS

A cross-sectional study conducted between May 18 and June 26, 2020, during which HCWs at a large inner-city teaching hospital in NYC received voluntary antibody testing. The main outcome was presence of SARS-CoV-2 antibodies indicating previous infection. Seroprevalence and adjusted odds ratios (aORs) for seropositivity by type and location of work were calculated using logistic regression analyses.

RESULTS

Of 2,749 HCWs tested, 831 tested positive, yielding a crude seroprevalence of 30.2% (95% CI, 29%-32%). Seroprevalence ranged from 11.1% for pharmacy staff to 44.0% for nonclinical HCWs comprised of patient transporters and housekeeping and security staff, with 37.5% for nurses and 20.9% for administrative staff. Compared to administrative staff, aORs (95% CIs) for seropositivity were 2.54 (1.64-3.94) for nurses; 2.51 (1.42-4.43) for nonclinical HCWs; between 1.70 and 1.83 for allied HCWs such as patient care technicians, social workers, registration clerks and therapists; and 0.80 (0.50-1.29) for physicians. Compared to office locations, aORs for the emergency department and inpatient units were 2.27 (1.53-3.37) and 1.48 (1.14-1.92), respectively.

CONCLUSION

One-third of hospital-based HCWs were seropositive for SARS-CoV-2 by the end of the first wave in NYC. Seroprevalence differed by job function and work location, with the highest estimated risk for nurses and the emergency department, respectively. These findings support current nationwide policy prioritizing HCWs for receipt of newly authorized COVID-19 vaccines.

摘要

目的

描述纽约市(NYC)大流行第一波后,按工作职能和工作地点划分的医护人员(HCWs)的 SARS-CoV-2 血清流行率和感染风险。

方法

这是一项在 2020 年 5 月 18 日至 6 月 26 日进行的横断面研究,期间 NYC 一家大型市内教学医院的 HCWs 接受了自愿抗体检测。主要结局是存在 SARS-CoV-2 抗体,表明曾有过感染。使用逻辑回归分析计算按工作类型和地点划分的血清阳性率和血清阳性的调整优势比(aOR)。

结果

在 2749 名接受检测的 HCWs 中,831 名呈阳性,粗血清流行率为 30.2%(95%CI,29%-32%)。药房工作人员的血清流行率最低为 11.1%,非临床 HCWs(包括患者转运工、保洁员和安保人员)最高为 44.0%,护士为 37.5%,行政人员为 20.9%。与行政人员相比,护士(95%CI,1.64-3.94)、非临床 HCWs(95%CI,1.42-4.43)、辅助 HCWs(如患者护理技术员、社会工作者、注册文员和治疗师)的 aORs 介于 1.70-1.83 之间,医生的 aORs 为 0.80(0.50-1.29)。与办公地点相比,急诊科和住院病房的 aORs 分别为 2.27(1.53-3.37)和 1.48(1.14-1.92)。

结论

在 NYC 大流行第一波结束时,三分之一的医院 HCWs 对 SARS-CoV-2 呈血清阳性。血清流行率因工作职能和工作地点而异,护士和急诊科的风险估计最高。这些发现支持当前全国范围内优先为 HCWs 接种新授权的 COVID-19 疫苗的政策。

相似文献

1
SARS-CoV-2 Seroprevalence Among Healthcare Workers by Job Function and Work Location in a New York Inner-City Hospital.在纽约市一家医院中,按工作职能和工作地点划分的医护人员中 SARS-CoV-2 血清流行率。
J Hosp Med. 2021 May;16(5):282-289. doi: 10.12788/jhm.3627.
2
Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up.荷兰医院医护人员在 2020 年第一波疫情后 SARS-CoV-2 抗体的血清阳性率:一项前瞻性随访的多中心横断面研究。
Antimicrob Resist Infect Control. 2023 Nov 29;12(1):137. doi: 10.1186/s13756-023-01324-x.
3
SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic.纽约市一家医院医护人员中新冠病毒血清流行率:COVID-19大流行期间的横断面分析
Int J Infect Dis. 2021 Jan;102:63-69. doi: 10.1016/j.ijid.2020.10.036. Epub 2020 Oct 16.
4
Seroprevalence of and Risk Factors Associated With SARS-CoV-2 Infection in Health Care Workers During the Early COVID-19 Pandemic in Italy.在 COVID-19 大流行早期,意大利医护人员中 SARS-CoV-2 感染的血清流行率及其相关危险因素。
JAMA Netw Open. 2021 Jul 1;4(7):e2115699. doi: 10.1001/jamanetworkopen.2021.15699.
5
SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.印度克什米尔地区不同工作场所暴露风险的医护人员中 SARS-CoV-2 血清流行率。
J Hosp Med. 2021 May;16(5):274-281. doi: 10.12788/jhm.3609.
6
SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran.伊朗德黑兰有新冠患者转诊的主要私立和公立医院中卫生保健工作者的 SARS-CoV-2 血清流行率。
Front Public Health. 2022 Mar 24;10:832003. doi: 10.3389/fpubh.2022.832003. eCollection 2022.
7
Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.爱尔兰医院医护人员中 SARS-CoV-2 抗体的流行情况。
Epidemiol Infect. 2021 Apr 27;149:e157. doi: 10.1017/S0950268821000984.
8
Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.医护人员中 SARS-CoV-2 抗体的血清流行率及相关因素:系统评价和荟萃分析。
J Hosp Infect. 2021 Feb;108:120-134. doi: 10.1016/j.jhin.2020.11.008. Epub 2020 Nov 16.
9
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.在 COVID-19 大流行的第一波和第二波期间,一家三级癌症中心的癌症患者和医护人员中 SARS-CoV-2 抗体的血清阳性率的平行进化和差异:canSEROcov-II 横断面研究。
Eur J Cancer. 2022 Apr;165:13-24. doi: 10.1016/j.ejca.2022.01.005. Epub 2022 Feb 1.
10
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.印度医护人员中 SARS-CoV-2 抗体的血清阳性率及其对感染控制实践的影响。
Indian J Med Res. 2021;153(1 & 2):207-213. doi: 10.4103/ijmr.IJMR_3911_20.

引用本文的文献

1
Understanding uptake of information about innovations among emergency department clinicians during the COVID-19 pandemic.了解新冠疫情期间急诊科临床医生对创新信息的接受情况。
J Am Coll Emerg Physicians Open. 2024 Jul 19;5(4):e13243. doi: 10.1002/emp2.13243. eCollection 2024 Aug.
2
Seroprevalence of SARS-CoV-2 in hospital workers in the southern region of Minas Gerais state in Brazil: An analysis of the pre-vaccine period.巴西米纳斯吉拉斯州南部地区医院工作者中 SARS-CoV-2 的血清流行率:疫苗接种前时期的分析。
Braz J Microbiol. 2023 Jun;54(2):859-871. doi: 10.1007/s42770-023-00966-8. Epub 2023 Apr 13.
3
SARS-CoV-2 infections and attitudes towards COVID-19 vaccines among healthcare workers in the New York Metropolitan area, USA.美国纽约大都市区医护人员中的 SARS-CoV-2 感染和对 COVID-19 疫苗的态度。
Fam Med Community Health. 2022 Jul;10(3). doi: 10.1136/fmch-2022-001692.
4
Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a tertiary care hospital in Riyadh, Saudi Arabia.沙特阿拉伯利雅得一家三级护理医院医护人员中新冠病毒2型抗体的血清流行率。
IJID Reg. 2022 Mar;2:51-54. doi: 10.1016/j.ijregi.2021.11.009. Epub 2021 Nov 29.
5
Prevalence of SARS-CoV-2 antibodies among nurses: A systematic review and meta-analysis.护士人群中 SARS-CoV-2 抗体的流行率:一项系统评价和荟萃分析。
J Clin Nurs. 2022 Jun;31(11-12):1557-1569. doi: 10.1111/jocn.16009. Epub 2021 Sep 27.

本文引用的文献

1
The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission-a living systematic review.无症状和症状前感染在 SARS-CoV-2 传播中的作用——一项实时系统评价。
Clin Microbiol Infect. 2021 Apr;27(4):511-519. doi: 10.1016/j.cmi.2021.01.011. Epub 2021 Jan 21.
2
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
3
Hospital-Acquired SARS-CoV-2 Infection: Lessons for Public Health.医院获得性新型冠状病毒感染:对公共卫生的启示
JAMA. 2020 Dec 1;324(21):2155-2156. doi: 10.1001/jama.2020.21399.
4
COVID-19 in a Correctional Facility Employee Following Multiple Brief Exposures to Persons with COVID-19 - Vermont, July-August 2020.2020 年 7 月至 8 月,美国佛蒙特州一名在惩教设施工作的员工在多次短暂接触新冠病毒感染者后感染 COVID-19。
MMWR Morb Mortal Wkly Rep. 2020 Oct 30;69(43):1569-1570. doi: 10.15585/mmwr.mm6943e1.
5
COVID-19-Associated Hospitalizations Among Health Care Personnel - COVID-NET, 13 States, March 1-May 31, 2020.COVID-19 相关医护人员住院情况 - COVID-NET,13 个州,2020 年 3 月 1 日至 5 月 31 日。
MMWR Morb Mortal Wkly Rep. 2020 Oct 30;69(43):1576-1583. doi: 10.15585/mmwr.mm6943e3.
6
SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic.纽约市一家医院医护人员中新冠病毒血清流行率:COVID-19大流行期间的横断面分析
Int J Infect Dis. 2021 Jan;102:63-69. doi: 10.1016/j.ijid.2020.10.036. Epub 2020 Oct 16.
7
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.美国大型全国范围内透析患者样本中 SARS-CoV-2 抗体的流行情况:一项横断面研究。
Lancet. 2020 Oct 24;396(10259):1335-1344. doi: 10.1016/S0140-6736(20)32009-2. Epub 2020 Sep 25.
8
SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study.SARS-CoV-2 血清流行率和医护人员无症状病毒携带情况:一项横断面研究。
Thorax. 2020 Dec;75(12):1089-1094. doi: 10.1136/thoraxjnl-2020-215414. Epub 2020 Sep 11.
9
Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020.2020 年 4 月至 6 月,13 家学术医疗中心多州医院网络中一线医护人员中 SARS-CoV-2 的血清阳性率。
MMWR Morb Mortal Wkly Rep. 2020 Sep 4;69(35):1221-1226. doi: 10.15585/mmwr.mm6935e2.
10
The effectiveness and efficacy of respiratory protective equipment (RPE) in dentistry and other health care settings: a systematic review.呼吸防护设备(RPE)在牙科和其他医疗保健环境中的有效性和功效:系统评价。
Acta Odontol Scand. 2020 Nov;78(8):626-639. doi: 10.1080/00016357.2020.1810769. Epub 2020 Sep 3.